Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Salymet is a topical analgesic cream developed and manufactured by the Vietnamese pharmaceutical company Pharmedic. It is a combination product containing methyl salicylate, menthol, and camphor, formulated for the symptomatic relief of musculoskeletal pain, including arthritis, rheumatism, neuralgia, and muscle strains. Methyl salicylate acts as a counter-irritant and a precursor to salicylic acid, which inhibits cyclooxygenase enzymes to reduce prostaglandin synthesis. Menthol and camphor function as topical analgesics by stimulating sensory nerves to produce cooling and warming sensations, effectively masking underlying pain through a counter-irritant mechanism. The product is marketed as an over-the-counter (OTC) generic treatment in Vietnam.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Salymet.